Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis
Clinical trial NCT02744222 · COMPLETED
Trial details
- NCT number
- NCT02744222
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-10
- Primary completion
- 2018-11-23
- Enrollment
- 399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.